Buy & Sell Biogen Inc (BIIB) – Biogen Inc Price Today
Aura AI Summary
Key Stats
- $28.61BMarket Cap
- HealthSector
- -10.16%3M Drawdown
- $30.89BEnterprise Value
- -Dividend Yield
- 109 daysTypical Hold Time
Biogen Inc (BIIB) is currently valued at a market capitalization of $28.61B, with an enterprise value of $30.89B. Over the past 52 weeks, Biogen Inc has traded between a low of $122.68 and a high of $204.53, highlighting its annual price range. Over the past three months, Biogen Inc has recorded a drawdown of -10.16%, reflecting recent price volatility. On average, investors hold Biogen Inc for approximately 109 days, indicating typical investor behavior on the platform.
About Biogen Inc
Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis. Aduhelm was approved as the firm's first Alzheimer's disease therapy in June 2021.
Most Recent News
Aerospace materials market to reach $89.58B by 2031, driven by lightweight composites and Asia-Pacific growth
The global aerospace materials market is projected to grow from $60.38 billion in 2026 to $89.58 billion by 2031, at a CAGR of 8.21%. Growth is fueled by rising demand for lightweight composite materials that improve fuel efficiency, increased satell...
State Street Global Advisors reduces stake in DCC plc to 1.39% after selling 1,250 shares.
State Street Global Advisors & Affiliates disclosed a sale of 1,250 ordinary shares of DCC plc on May 22, 2026, at a price of €61.55 per share. Following this transaction, their total holding in DCC plc stands at 1,189,951 shares, representing 1.3929...
NevGold's Nevada project hits antimony in every drillhole, aiming for 2027 production to boost US critical mineral supply.
NevGold Corp. reported that all 17 drillholes at its Limousine Butte project in Nevada returned consistent oxide antimony and gold mineralization, with notable grades such as 0.32% antimony over 14.9 meters. This brownfield site contains historic cru...